- Michigan GOP Senate hopeful reminds government is the ‘servant’
- Christmas, by Congress: Members mull a 15-cent tax on trees
- U.S. unemployment falls to five-year low of 7 percent; 203K jobs added
- World mourns Nelson Mandela and celebrates his life; burial set for Dec. 15
- Bill O’Reilly reminds: Nelson Mandela ‘was a communist’
- John Boehner says GOP should support gay candidates: ‘I do’
- Grass-Whopper: Pan-fried cricket burgers go over big in New York City
- CDC sees measles spike and ‘failure to vaccinate’
- Ex-Secret Service agent seeking Md. seat: Everyone’s a ‘de facto criminal’ now
- New prosthetic hand technology lets amputees feel again
Independent voices from the The Washington Times Communities
Topic - Deb Matthews
Canada's federal government allowed the approval process to proceed Monday for the generic form of the highly-addictive painkiller OxyContin, a move that set off a quick outcry from the country's provinces and aboriginal communities.
"I am profoundly disappointed in minister Aglukkaq's decision to ignore the threat to public safety posed by generic OxyContin and to allow it to enter the Canadian market," Ontario Health Minister Deb Matthews said in a statement.
While national figures are hard to come by, Matthews said OxyContin has led to a five-fold increase in oxycodone-related deaths.